In April 2022, MilliporeSigma announced the acquisition of MAST® Aseptic Sampling System platform from Lonza, adding fully automated sampling to MilliporeSigma’s bioprocessing portfolio.
The MAST® Platform is an automated, aseptic bioreactor sampling system designed to advance bioprocessing capabilities for more efficient and cost-effective drug manufacturing.
Read the full press release.
For customer inquiries and to obtain more information about the MAST® System, please visit: http://mastsampling.com